Personalized Chemotherapy Regimes

Personalized Chemotherapy Regimes

Supported by the MIT-Madrid M+Visión Consortium, Team Leuko aims to develop home-based test of white blood cells that enables physicians to personalize chemotherapy and increase cancer survival.